Skip to main content
. 2024 May 3;38(3):1443–1447. doi: 10.21873/invivo.13587

Table I. Clinical data and immuno-histochemical characteristics of the tumors.

graphic file with name in_vivo-38-1445-i0001.jpg

ER: Estrogen receptor; PR: progesterone receptor; SLN: sentinel lymph node; RS: OncotypeDX recurrence score; ER/PR score >50: Positive (300=maximum value).